{"id":20404,"date":"2015-05-13T23:01:39","date_gmt":"2015-05-13T23:01:39","guid":{"rendered":"https:\/\/patientbloodmanagement.org\/resources\/la-eritropoyetina-y-la-neuroproteccion-neonatal\/"},"modified":"2024-05-23T12:59:22","modified_gmt":"2024-05-23T12:59:22","slug":"la-eritropoyetina-y-la-neuroproteccion-neonatal","status":"publish","type":"resources","link":"https:\/\/patientbloodmanagement.org\/es\/resources\/la-eritropoyetina-y-la-neuroproteccion-neonatal\/","title":{"rendered":"La eritropoyetina y la neuroprotecci\u00f3n neonatal"},"content":{"rendered":"\n<p>Juul SE. Mascotas GC.<\/p>\n\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26250911\" target=\"_blank\" rel=\"noopener\">Resumen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Juul SE. Mascotas GC. Resumen<\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","categories":[274],"tags":[],"class_list":["post-20404","resources","type-resources","status-publish","hentry","category-agentes-estimulantes-de-la-eritropoyesis-aee"],"acf":[],"_links":{"self":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources\/20404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/users\/1"}],"wp:attachment":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/media?parent=20404"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/categories?post=20404"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/tags?post=20404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}